Damora Therapeutics, Inc. logo

Damora Therapeutics, Inc. (DMRA)

Market Open
11 Sep, 14:04
NASDAQ (NMS) NASDAQ (NMS)
$
27. 59
+0.75
+2.7943%
$
- Market Cap
- P/E Ratio
- Div Yield
26,354 Volume
- Eps
$ 26.84
Previous Close
Add Transaction
Day Range
27.32 28.38
Year Range
2.53 38.33
Want to track DMRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Damora Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
BG
Bart Gancher Intech Investment Management LLC
9,505 $203,597.1 $284,389.6 $80,792.5 39.68%
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
48,754 $1.26M $1.51M $250,595.62 19.85%
Joseph Castro
Joseph Castro Nuveen LLC
149,592 $3.2M $4.16M $951,405.12 29.69%
KJ
Ken Joseph Braidwel LLP
1.62M $38.72M $45.12M $6.4M 16.54%
Kevin Roan
Kevin Roan Stempoint Capita LLP
216,194 $4.63M $6M $1.37M 29.65%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
8 $171.36 $214.72 $43.36 25.3%
Ilko Menkov
Ilko Menkov Vestal Point Capita LLP
575,000 $14.89M $15.97M $1.08M 7.22%
Raymond Debbane
Raymond Debbane Siren, L.L.C.
900,000 $23.31M $27.9M $4.59M 19.69%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
15,745 $337,257.9 $475,184.1 $137,926.2 40.9%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
8,084 $197,073.32 $241,388.24 $44,314.92 22.49%